Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Drug sensitivity screening and genomic characterization of 45 HPV-negative head and neck carcinoma cell lines for novel biomarkers of drug efficacy.

Lepikhova T, Karhemo PR, Louhimo R, Yadav B, Murumägi A, Kulesskiy E, Kivento M, Sihto H, Grénman R, Syrjänen SM, Kallioniemi O, Aittokallio T, Wennerberg K, Joensuu H, Monni O.

Mol Cancer Ther. 2018 Jul 3. pii: molcanther.0733.2017. doi: 10.1158/1535-7163.MCT-17-0733. [Epub ahead of print]

PMID:
29970484
2.

Fibroblast spheroids as a model to study sustained fibroblast quiescence and their crosstalk with tumor cells.

Salmenperä P, Karhemo PR, Räsänen K, Laakkonen P, Vaheri A.

Exp Cell Res. 2016 Jul 1;345(1):17-24. doi: 10.1016/j.yexcr.2016.05.005. Epub 2016 May 10.

PMID:
27177832
3.

Liprin-α1 is a regulator of vimentin intermediate filament network in the cancer cell adhesion machinery.

Pehkonen H, von Nandelstadh P, Karhemo PR, Lepikhova T, Grenman R, Lehti K, Monni O.

Sci Rep. 2016 Apr 14;6:24486. doi: 10.1038/srep24486.

4.

Metastasis-associated cell surface oncoproteomics.

Karhemo PR, Hyvönen M, Laakkonen P.

Front Pharmacol. 2012 Nov 7;3:192. doi: 10.3389/fphar.2012.00192. eCollection 2012.

5.

An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Karhemo PR, Ravela S, Laakso M, Ritamo I, Tatti O, Mäkinen S, Goodison S, Stenman UH, Hölttä E, Hautaniemi S, Valmu L, Lehti K, Laakkonen P.

J Proteomics. 2012 Dec 21;77:87-100. doi: 10.1016/j.jprot.2012.07.009. Epub 2012 Jul 17.

6.

An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer.

Karhemo PR, Rivinoja A, Lundin J, Hyvönen M, Chernenko A, Lammi J, Sihto H, Lundin M, Heikkilä P, Joensuu H, Bono P, Laakkonen P.

Am J Pathol. 2011 Aug;179(2):1004-14. doi: 10.1016/j.ajpath.2011.04.009. Epub 2011 Jun 2.

Supplemental Content

Loading ...
Support Center